Guangzhou Wondfo Biotech Co (SZSE:300482) EPS (Basic): ¥-0.34 (TTM As of Mar. 2026)


SZSE:300482 Guangzhou Wondfo Biotech Co Ltd SZSE:300482
79 GF Score
Price ¥17.30
GF Value ¥16.75
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Guangzhou Wondfo Biotech Co EPS (Basic)?

Guangzhou Wondfo Biotech Co SZSE:300482 -2.09% 79 EPS (Basic) is ¥-0.34 as of Mar. 2026. GuruFocus rates SZSE:300482 with a GF Score™ of 79/100 and a GF Value™ of ¥16.75 (Fairly Valued). The stock has 5 warning signs investors should review.

Guangzhou Wondfo Biotech Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ¥0.18. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-0.34.

Guangzhou Wondfo Biotech Co's EPS (Diluted) for the three months ended in Mar. 2026 was ¥0.18. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-0.34.

Guangzhou Wondfo Biotech Co's EPS without NRI for the three months ended in Mar. 2026 was ¥0.18. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.32.

During the past 12 months, Guangzhou Wondfo Biotech Co's average EPS without NRIGrowth Rate was -128.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Guangzhou Wondfo Biotech Co's highest 3-Year average EPS without NRI Growth Rate was 45.30% per year. The lowest was -11.40% per year. And the median was 26.30% per year.

Guangzhou Wondfo Biotech Co  (SZSE:300482) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Guangzhou Wondfo Biotech Co EPS (Basic) Related Terms

Guangzhou Wondfo Biotech Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Guangzhou Wondfo Biotech Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Wondfo Biotech Co EPS (Basic) Chart

Guangzhou Wondfo Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.43 2.71 1.10 1.21 -0.13

Guangzhou Wondfo Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.00 -0.11 -0.41 0.18
SZSE:300482
79GF Score
Guangzhou Wondfo Biotech Co Ltd SZSE:300482
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Wondfo Biotech Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Guangzhou Wondfo Biotech Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-63.025-0)/484.807
=-0.13

Guangzhou Wondfo Biotech Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(84.4-0)/468.886
=0.18

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ¥-0.34 mean?
Guangzhou Wondfo Biotech Co (SZSE:300482) has a EPS (Basic) of ¥-0.34 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Guangzhou Wondfo Biotech Co and its competitors.
Is Guangzhou Wondfo Biotech Co's EPS (Basic) too high?
Guangzhou Wondfo Biotech Co's current EPS (Basic) is ¥-0.34. Overall, Guangzhou Wondfo Biotech Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Wondfo Biotech Co's EPS (Basic) compare to ABT and SYK?
Guangzhou Wondfo Biotech Co's EPS (Basic) of ¥-0.34 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Guangzhou Wondfo Biotech Co and its competitors. Guangzhou Wondfo Biotech Co's current EPS (Basic) is ¥-0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Wondfo Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Wondfo Biotech Co (SZSE:300482) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.75, compared to a current price of ¥17.30 — trading 3.3% above its estimated fair value. The current EPS (Basic) is ¥-0.34. Guangzhou Wondfo Biotech Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Guangzhou Wondfo Biotech Co (SZSE:300482), the current EPS (Basic) is ¥-0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Wondfo Biotech Co (SZSE:300482) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Wondfo Biotech Co stock appears to be overvalued. The current stock price of ¥17.30 is trading 3.3% above its estimated GF Value™ of ¥16.75. GuruFocus considers Guangzhou Wondfo Biotech Co to be Fairly Valued.

Key valuation signals for SZSE:300482:

  • EPS (Basic): ¥-0.34
  • GF Value™: ¥16.75 vs. price of ¥17.30 (3.3% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the SZSE:300482 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou Wondfo Biotech Co Business Description

Address No. 8, Lizhishan Road, Science City, Luogang District, Guangdong Province, Guangzhou, CHN, 510641
Guangzhou Wondfo Biotech Co Ltd is engaged in the research, development, production and sales of POCT-related products such as rapid diagnostic reagents and rapid testing instruments. Its products are sold in various countries and regions, and are widely used in clinical testing, critical care, chronic disease management, primary healthcare, epidemic monitoring, disaster relief, on-site law enforcement, and family and personal health management.
79GF Score

Get the complete analysis for SZSE:300482

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.30
Price
¥16.75
GF Value